Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 18:2021:6904858.
doi: 10.1155/2021/6904858. eCollection 2021.

Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome

Shereen Shawky  1 , Hesham Safouh  2 , Mona Gamal  3 , Mohammed M Abbas  3 , Azza Aboul-Enein  1 , Toshihiro Sawai  4 , Yosra Fahmy  2 , Heba Selim  1
Affiliations

Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome

Shereen Shawky et al. Int J Nephrol. .

Abstract

Background: Atypical hemolytic uremic syndrome (aHUS) is an important cause of acute kidney injury in children. It is primarily caused by dysregulation of the complement alternative pathway due to genetic mutations, mainly in complement factor H genes, or due to anti-factor H autoantibodies (anti-FH), leading to uncontrolled overactivation of the complement system. Early diagnosis and treatment of autoimmune HUS (AI-HUS) is essential and leads to a favorable outcome.

Methods: Fifty pediatric HUS patients and 50 age- and sex-matched controls were included in the study. Patients were subjected to full history taking, clinical examination, and laboratory testing. All candidates were subjected to an assessment of anti-FH in serum by a homemade enzyme-linked immunosorbent assay technique.

Results: A high frequency of serum anti-FH was detected in our aHUS patients. The disease onset of AI-HUS was mainly observed in March and April, with significantly higher rates in school-aged males. All patients who started immunosuppressives early together with plasmapheresis upon detection of their anti-FH had complete renal function recovery.

Conclusion: The high frequency of AI-HUS revealed in Egyptian HUS children in our study highlights the importance of implementing anti-FH testing in Egypt to provide early recognition for immediate proper management, including early immunosuppressive therapy, and hence improving patient outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Brocklebank V., Wood K. M., Kavanagh D. Thrombotic microangiopathy and the kidney. Clinical Journal of the American Society of Nephrology . 2018;13(2):300–317. doi: 10.2215/CJN.00620117. - DOI - PMC - PubMed
    1. Jacobs E., Ortiz C., Licht C. The role of complement in the pathogenesis of HUS and the TMA spectrum disorders. Current Pediatrics Reports . 2019;15(7):1–11. doi: 10.1007/s40124-019-00186-5. - DOI
    1. Sethi S. K, Raina R., McCulloch M., Bunchman T. E. Critical Care Pediatric Nephrology and Dialysis: A Practical Handbook . Berlin, Germany: Springer; 2019.
    1. Guo W.-Y., Song D., Song D., et al. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome. Pediatric Nephrology . 2019;34(2):269–281. doi: 10.1007/s00467-018-4074-4. - DOI - PubMed
    1. Schaefer F., Ardissino G., Ariceta G., et al. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney International . 2018;1(94):408–418. doi: 10.1016/j.kint.2018.02.029. - DOI - PubMed

LinkOut - more resources